Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomas.
Yin J, Jung JE, Choi SI, Kim SS, Oh YT, Kim TH, Choi E, Lee SJ, Kim H, Kim EO, Lee YS, Chang HJ, Park JY, Kim Y, Yun T, Heo K, Kim YJ, Kim H, Kim YH, Park JB, Choi SW.
Yin J, et al. Among authors: choi sw, choi e, choi si.
Cancer Lett. 2018 Feb 1;414:181-189. doi: 10.1016/j.canlet.2017.11.013. Epub 2017 Nov 15.
Cancer Lett. 2018.
PMID: 29154973